Skip to content
About
Our products
Biotech
BEGESAND® (Inn: Begelomab)
Pharma
PHELINUN® (Inn: Melphalan)
TEPADINA® (Inn: Thiotepa)
Canadian Product Monograph
Manufacturing
CDMO
CDMO Services
Sterile Injectable Products
Biologics
Innovative Ready To Use Systems
Lyo bag® technology
Fill-Choice
Capabilities
Aseptic Filling
Dispensing
Compounding areas
Annex 1 Compliant automatization
Terminal Sterilization
CCIT
Inspection
Cold Chain Storage
R&D
Biotech
Our Pipeline
Pharma
Technology innovations
Careers
News
Contacts
For Medical Inquiries / Per Richieste Mediche
To Notify Side Effects / Per Segnalare Effetti Collaterali
Compounding areas
Adienne_admin
2025-11-05T13:27:52+00:00
Compounding areas
Multiple Compounding areas with SS vessel from 50 to 10,000L.
Page load link
Go to Top